| NO |
Title |
Date |
Submission Obligator |
| 10 |
Other Management Information(Voluntary Disclosure) |
2020/05/25 |
HANALL BIOPHARMA CO.,LTD |
| 9 |
Interim Report on Business Performance(Fair Disclosure) |
2020/05/08 |
HANALL BIOPHARMA CO.,LTD |
| 8 |
Suspension of Trading and Resumption of Trading Thereafter(As a result of Disclosure of Important Corporate Information) |
2020/05/08 |
HANALL BIOPHARMA CO.,LTD |
| 7 |
Suspension of Business Operation |
2020/05/08 |
HANALL BIOPHARMA CO.,LTD |
| 6 |
[Investment Caution] Issue traded by linked accounts with high market influence |
2020/03/30 |
HANALL BIOPHARMA CO.,LTD |
| 5 |
Outcome of Annual Shareholders' Meeting |
2020/03/20 |
HANALL BIOPHARMA CO.,LTD |
| 4 |
Reporting reasons for holding general shareholders' meeting on the most concentrated date |
2020/03/05 |
HANALL BIOPHARMA CO.,LTD |
| 3 |
Decision on Calling Shareholders' Meeting |
2020/03/03 |
HANALL BIOPHARMA CO.,LTD |
| 2 |
Submission of Audit Report |
2020/02/26 |
HANALL BIOPHARMA CO.,LTD |
| 1 |
Implementation and Operation of Compliance Program of the Fair Trade Commission |
2020/02/03 |
HANALL BIOPHARMA CO.,LTD |